241 Avsnitt

  1. Biotech Capital Markets Forecast With Allan Shaw

    Publicerades: 2022-01-24

  2. Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias

    Publicerades: 2022-01-17

  3. Precision Approach To Infectious Disease With Locus Biosciences' Paul Garofolo

    Publicerades: 2022-01-10

  4. Bioengineering Human Tissue With Humacyte's Dr. Heather Prichard

    Publicerades: 2022-01-03

  5. The Top Stories Of 2021 With Allan Shaw

    Publicerades: 2021-12-27

  6. Complete CAR T Manufacturing Control with Cellectis' Steve Doares

    Publicerades: 2021-12-20

  7. Genomically-Guided Medicine with Elevation Oncology's Shawn Leland, PharmD, RPh

    Publicerades: 2021-12-13

  8. Inhalable mAbs & Vaccines with TFF's Glenn Mattes

    Publicerades: 2021-12-06

  9. Democratizing Biologics With Lumen Bioscience's Brian Finrow, J.D. & Craig Behnke, Ph.D.

    Publicerades: 2021-11-29

  10. Cornering The Antibody Market With Akesobio CEO Dr. Michelle Xia, Ph.D.

    Publicerades: 2021-11-22

  11. Turning The Liver Into A mAb Factory With Homology's Arthur Tzianabos, Ph.D.

    Publicerades: 2021-11-15

  12. Maximizing mRNA With Precision Nanosystems' James Taylor, Ph.D.

    Publicerades: 2021-11-08

  13. Foundations Of Flexible Manufacturing With Sarepta Therapeutics' Brian Winstead

    Publicerades: 2021-11-01

  14. The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma

    Publicerades: 2021-10-25

  15. The Clinical Trials Conundrum with Allan Shaw

    Publicerades: 2021-10-18

  16. CMC Developability Assessments For Rapid Ph.1 Entry with AltruBio's Gene Lee, Ph.D.

    Publicerades: 2021-10-11

  17. CDMO With A Pipeline with Forge Biologics President & CEO Dr. Timothy J. Miller

    Publicerades: 2021-10-04

  18. Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.

    Publicerades: 2021-09-27

  19. From Bayer To Startup Bio With AltruBio's Dr. Judy Chou

    Publicerades: 2021-09-20

  20. Creating Competitive Differentiation With Allan Shaw

    Publicerades: 2021-09-13

9 / 13

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

Visit the podcast's native language site